Pandemic News: Another Treatment Candidate

This is preliminary data from a combined Phase 2/3 clinical trial, so they are still confirming the dosing along with the tolerance, but the preliminary results from this Pfizer trial are even better than those from the Merck drug. Which suggests that COVID may soon be something that is survive-able for more people!

An 89% reduction is AMAZING, and it will be good to see what the final analysis shows.

This warms my heart. We could all use some more hope for better outcomes with this terrible pandemic.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.